-
Nephrology Drugs Market Projected to Reach $22.61 Billion with 6.3% CAGR by 2029
25 Nov 2025 00:00 GMT
… drugs, emphasis on precision medicine and individualized treatment … GlaxoSmithKline plc
• Teva Pharmaceutical Industries Limited
What Are … Phase III clinical trials, including hepcidin downregulation … Agents: Epoetin Alfa, Darbepoetin Alfa
3) By …
-
Darbepoetin Alfa (Aranesp) Market CAGR to be at 5% from 2025 to 2029 | $7.37 Billion Industry Revenue by 2029
24 Nov 2025 10:00 GMT
… UK-based pharmaceutical and biotechnology enterprise, unfolded a new treatment approved by … Food and Drug Administration (FDA) in February 2023. This treatment, called … In The Darbepoetin Alfa (Aranesp) Market Report?
The darbepoetin alfa (aranesp) market …
-
Health Biotech Strengthens Global Footprint at CPHI Frankfurt 2025
31 Oct 2025 12:34 GMT
… making reliable and affordable medicines accessible worldwide, built on a … of recombinant DARBEPOETIN ALFA.
Health Biotech produces close to 1,000 pharmaceuticals across major … , syrups, ointments and latest drug delivery systems.
For more information, …
-
Darbepoetin-alpha Regulates Apelin and Galectin-3 in Insulin Resistance
28 Oct 2025 01:40 GMT
… -resistant state, followed by treatment with darbepoetin-alpha. The researchers meticulously … darbepoetin-alpha treatment suggests a potential anti-inflammatory effect of the drug … within the context of darbepoetin-alpha treatment lays the groundwork for …
-
FDA use of Real-World Evidence in Regulatory Decision Making
23 Sep 2025 03:56 GMT
… (severe hypocalcemia). FDA Drug Safety Communication: FDA adds Boxed … Pharmaceuticals, Inc
Medicare claims data
Retrospective cohort study
In FDA … clinical trial used to approve Pradaxa. FDA … Internal Medicine publication, 2021.
EPOGEN, PROCRIT, ARANESP ( …
-
Nurse accused of failing to give critical medication on several occasions
10 Sep 2025 01:20 GMT
… December 2022 to administer prescribed Aranesp medication, used to treat low … Resident A had received the Aranesp injections in late 2022. … Ms Mangena told a doctor that the resident had died … that ibandronic acid, a treatment to prevent symptoms caused by …
-
Dei BioPharma wins FDA nod in $300bn diabetes, obesity drug race
21 Aug 2025 14:28 GMT
… advanced corners of the pharmaceutical industry, and it could … development plan of darbepoetin alfa, a drug used to treat … almost no treatment options. For them, Dei’s FDA milestone … full market license. Rigorous trials, compliance checks, and regulatory …
-
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Rectal Cancer - Dr. Poulami Basu
07 Aug 2025 15:36 GMT
… symptomatic anemia—posing challenges to treatment continuation and overall well-being … discusses how timely administration of darbepoetin alfa played a pivotal role … Hospital, Kolkata. Her expertise includes Medical and Hemato-Oncology, Immunotherapy, and …
-
Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United Kingdom
24 Jun 2025 14:26 GMT
… deferoxamine, deferasirox, deferiprone, darbepoetin, epoetin, granulocyte colony-stimulating … treatment costs, while the first-line drug … compared with clinical trials. It is … Medicines Corporation; speakers’ bureau for Astellas Pharma, Jazz Pharmaceuticals …
-
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic gallbladder cancer - Dr AVS Suresh
09 Jun 2025 07:55 GMT
… Dr. AVS Suresh, Senior Consultant Medical Oncologist and Hematologist at Continental … how darbepoetin alfa helped improve and maintain hemoglobin levels, enhanced treatment tolerance … He is a Senior Consultant Medical Oncologist and Hematologist at Continental …